Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I didn't say the "toxin market." I said the happenings of therapeutic Daxxify. Have you read every post on this board? Listened to every Revance earnings call and conference? Read every Revance filing?
You're new here and from your own words clearly not up to speed on all the happenings of therapeutic Daxxify.
If the 1:1 unit dosing holds up Daxxify will capture the vast majority of the CD market share and quickly as patients will be getting better relief for half the price. That will validate the Daxxify difference that many unscrupulous CosmeticMDs have tried so hard to hide from their patients. It will also provide the credibility Revance needs to ink a partnership to expand the therapeutic indications for Daxxify.
Welcome to the Revance board. There's a sizable group of bears here who spread lies about Daxxify. None of these RVNCQ clowns has been able to actually refute that Daxxify is the best toxin on the market—but we've seen degenerate doctors who claim Daxxify "doesn't work" while lying about shorting the stock. Why would any patient not want the best toxin on the market at the same price as Botox? Because their "CosmeticMD" steered them towards an inferior product for a kickback. The aesthetics business is dirty. Clearly, this market is temperamental about loss making companies with substantial debt in the face of uncertainty about interest rates. Might the liars be able to keep patients away from the best toxin long enough to bankrupt Revance? Certainly, but it's unlikely. GLTA.
The clown who objected to being tagged with a clown emoji said sales were flat in Q4 when units were up 22%.
RVNC is hyper-sensitive to interest rates. The hot PPI report today sent rates higher and stocks tumbling. Ironically, Revance's recent capital raise makes them less sensitive to rates, but the market is not always rational, and as you pointed out investors have lost confidence in Foley. Revance needs to string some strong quarters together to get out of the penalty box and restore investor confidence, but today's sell-off is not related to operational issues.
CosmeticMD is a complete loser. He has a failing business and an unsatisfied wife. His life is so pathetic that he lies about being short RVNC and then reads this board every day in case I mention him. Rumor is his Galderma rep offered to cover some of his upcoming alimony payments if he shills Dysport.
This was the best Foley has sounded in a long time—possibly ever. Props to the Cowen analyst for not letting him get away with squishy language. Foley did conveniently leave out that his profligate spending and bad acquisitions forced this raise near all-time lows. I'd accept a significant (much more than 30k) open-market purchase from him in lieu of an apology. Foley also blew it by being arrogant and not understanding the "CosmeticMD effect"—that many providers in aesthetics have big opinions but often small brains and significant conflicts of interest. The dermatology community should be ashamed of themselves. Imagine a neurologist telling their patient that Dysport is just as good and then getting a nice kickback from Galderma! Therapeutics will help to prove the Daxxify difference and support the RVNC story but this was the first time I heard Mark seem to understand that aesthetics is going to be fought in the trenches and he's going to have to pander to some personalities to convert accounts.
The time to onboard new accounts with Daxxify will continue to decrease.
Besides the obvious sharing of best practices curated by astute providers like soma2022, the pressure is building on injectors to offer Daxxify. The death of the "no advertising price" strategy will only increase that pressure. Aesthetics sadly has many practitioners who think they're smarter than they really are (the "CosmeticMD effect")—when Daxxify wasn't immediately a drop-in replacement for Botox with 2x the duration these people were more than eager to jump on the Daxxify hate-train (many with financial incentives to do so). However, as Daxxify continues to deliver excellent real-world results amongst their colleagues, these people have been outed for the clowns they always were. This was a one-time process with the release of a new product and will not be repeated with each new wave of adopters.
@Emannow: "No price-advertising" policy is officially DEAD!
Richard Gonzalez to retire from ABBV July 1st.
https://news.abbvie.com/2024-02-20-AbbVie-Announces-Appointment-of-Robert-A-Michael-as-Chief-Executive-Officer
I did a LYFT. U.S. 10Y up 30bp* since the start of February.
RVNC does not exist in isolation.
The U.S. 10Y is up 300bp since the start of February. Fund managers are, as always, overly focused on alpha in the current quarter. The current market sentiment is "show me the money" and Revance has said they won't have any real earnings until probably 2026.
A lot of people on this board think I'm an as*hole—which I am—but there's a reason I've been so brash about Daxxify. It turns out that the data really is more reliable than the groupthink of a bunch of doctors. Any doctor who says Daxxify "doesn't work" or can't get good results has ironically, and somewhat hilariously, outed themselves. The CosmeticMD episode demonstrates how dumb doctors can be.
I added some shares myself this past week after the borabora indicator turned lush green. 😂
That's a big enough buy that I can't really call you RVNCQ anymore. Of course, I don't know how that compares to your EOLS position.
I suspect you'll start offering Daxxify when a few important clients ask about it and you get concerned they might go elsewhere to get it.
It's happening:
Exactly!
The problem here is the injector/practice. Overcharging for a product they don't know how to use properly. And yet they still converted 50% of patients! 😂
That's a fair point, but it also sounds like a total cop out. These products inherently require tailoring to individual users for best results. These smart people that went to medical school can't figure it out? Daxxify provides the best patient outcome of any toxin on the market. With the new price it's also the best value toxin on the market. At this point, Daxxify is a test: if a provider is not offering and recommending it to their patients then they failed. From a consumer's perspective there's really no other way to put it.
I disagree. I was speaking generally, not specifically about your contacts. Preparing Daxxify isn't that challenging. Laziness and greed are two sides of the same coin. They want to maximize profit for themselves (in as little time as possible), not outcomes for their patients.
Addendum: come to think of it, it's actually more laziness than greed. Why? Because @soma2022's protocol allows providers to make more money using Daxxify.
Proof that aesthetics providers are dumb, lazy, and greedy!
Clearly she's not very well informed, given that she says the biggest drawback of Daxxify is price. That makes me question how well informed her injection technique is as well. Aesthetics really is a business with too many opinions which unfortunately makes it harder for the objectively better product to win out.
Agreed. However, the unit value is not arbitrary (see below). Given the unfortunate 2:1 unit translation to Botox and the claims of double the duration, Revance should have realized people were going to make this mistake and they should communicate more clearly that each unit contains half the toxin of a Botox unit.
Nobody wants Daxxify.
@boraborak38 had a chat with his EOLS rep and they both agreed that Jeuveau is just as good as Daxxify, and all the doctors pushing Daxxify are just shills for Revance.
Oh thank you, my mistake!
I was just about to say that @boraborak38 will protest that he's a RVNC shareholder so how can he be RVNCQ?
Here's how:
I linked this already, but it's a good one. I wonder what @boraborak38 thinks about the massive Daxxify adoption Dr. Pozner is seeing.
I guess everybody here should ignore all these doctors who are putting their name and reputation on the line to tout Daxxify and instead listen to an anonymous supposed clinic owner and EOLS shareholder on this message board.
Make no mistake: @boraborak38 is RVNCQ.
Yet another little personal anecdote about how great EOLS is and how bad he feels for RVNC. No ill will. Just an inferior product right?
It seems that Revance has been slow to update the practice locator but it's hard to say with exact certainty. It's something that the new marketing team needs to improve upon and Foley needs to answer for.
I'm not in the Miami area myself so I'm not familiar with the local practices, I just happen to have seen White Coat Beauty on Instagram recently and they seem to have a very sizable following.
Good luck and it would be great to hear about your experience whoever you end up going with.
Give what a rest exactly? Exposing liars?
Neither do I. But CosmeticMD came here specifically to spread lies.
So a loser and professional failure clutching to his Galderma kickback checks comes here specifically to spread lies about Daxxify, then lies about being short the stock, gets caught lying because he's dumb and careless (the real reason his business is failing) but @boraborak38 says there's no war against RVNC from those whose financial interests will be harmed by Daxxify. 🤡
All he's got now is to point to the past. Smart money looks to the future.
In a year from now when Daxxify is dominating, CosmeticMD will claim he was long RVNC. 😂
Trends 2024 facial injectables.
Board certified plastic surgeon.
https://www.instagram.com/reel/C2id52jJlcG/?igsh=ZWtxZ3c2aDJqZGtn
Somebody should probably warn perpetual-loser CosmeticMD's patients that they're getting a substandard product and service.
Do you mean the investor pre-announcement? That had the following language:
Thanks! The video doesn't mention a 75% reorder rate. Was that communicated separately?
CosmeticMD lied because he's a liar.
It's cute that he's concocted that little story now—4 months later—to try to explain his lie. He lied about being short because he's dumb and sloppy—exactly how he runs his clinic.
This loser's story is that he lied about being short to avoid being labeled a FUDster but then one week later suddenly that was no longer a concern.
He lied about being short because he's a useless shitposter who doesn't even remember what other lies he's previously told.
He came here to this board specifically with the intent to spread lies about Daxxify.